Surgify Halo™ — a bone-cutting burr that distinguishes hard tissue from soft: it cuts bone at rates comparable to conventional burrs while protecting nerves, blood vessels and central nervous system tissue in head, neck and spine procedures. Both MDR- and FDA-approved. Aalto University spin-off; CEO and co-founder Visa Sippola.
Surgify Medical is one of 33 companies in Medtech & Digital Health. The others:
Every row on this map is checked by hand against the trade register and the company's own material, and placed in the sector that best describes its business or its technology. Service firms and consultancies are left out, however advanced the technology they work with — the test is where the revenue comes from. Only funding figures the company or its investor has published are shown. The full rules are on the landscape ↗